Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
5
Stocks News & Analysis
stocks
Tesla: Full self-driving approval in China supports our view for deliveries growth in 2024
Our analyst takes a different view from the headlines and market reaction.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks
Aussie tech leader reports earnings
Positive signs of revenue growth being converted into positive cash flow.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,835.20 | 96.80 | -1.22% |
| CAC 40 | 7,984.93 | 80.22 | -0.99% |
| DAX 40 | 17,932.17 | 186.15 | -1.03% |
| Dow JONES (US) | 37,815.92 | 570.17 | -1.49% |
| FTSE 100 | 8,144.13 | 2.90 | -0.04% |
| HKSE | 17,763.03 | 16.12 | 0.09% |
| NASDAQ | 15,657.82 | 325.26 | -2.04% |
| Nikkei 225 | 38,177.76 | 227.90 | -0.59% |
| NZX 50 Index | 11,877.02 | 80.48 | -0.67% |
| S&P 500 | 5,035.69 | 80.48 | -1.57% |
| S&P/ASX 200 | 7,572.40 | 91.70 | -1.20% |
| SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |
| Peninsula Energy Ltd PEN | 0.12 | 0.01 | 6.82% |
| Link Administration Holdings Ltd LNK | 2.26 | 0.01 | 0.22% |
| South32 Ltd S32 | 3.49 | 0.10 | -2.79% |
| The Star Entertainment Group Ltd SGR | 0.41 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | -3.45% |
| Mesoblast Ltd MSB | 1.03 | 0.04 | 3.54% |
| Endeavour Group Ltd EDV | 5.12 | 0.24 | -4.48% |
| Red 5 Ltd RED | 0.43 | 0.03 | -5.56% |
| Anson Resources Ltd ASN | 0.12 | 0.02 | 14.29% |